Article

AMO unveils WhiteStar Signature phaco system with advanced fluidic technology

Advanced Medical Optics Inc. (AMO) announces the launch of the WhiteStar Signature phacoemulsification system with Fusion fluidics.

Advanced Medical Optics Inc. (AMO) announces the launch of the WhiteStar Signature phacoemulsification system with Fusion fluidics.

The advanced technology combines the performance of AMO's WhiteStar system with the safety of a revolutionary dual-pump fluidic system, according to the company. A streamlined user interface and easy-to-use accessories enhance efficiency of the operating room environment.

"The WhiteStar Signature system combines the efficiency and safety of WhiteStar phaco technology with improved fluidics that enhance chamber stability," said David Chang, MD, clinical professor of ophthalmology, University of California, San Francisco. "The dual pump represents the next generation in phaco fluidics, and the new user interface is a significant improvement for surgeons and staff."

The new fluidics technology provides chamber stability and effectively reduces post-occlusion surge by a significant margin, according to the company. The dual pump responsiveness has the performance of a venturi pump and the control of a peristaltic flow-based pump to provide a stable environment for the surgeon and patient. The user-friendly system includes a one-step, one-hand cassette, intuitive touch screen, and intelligent help feature.

For more information, visit AMO at Booths 941 and 1241.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.